向下滚动
Redefining Universal CAR-T
Without Cutting a Single Gene.
About Wondercel Therapeutics
Wondercel Therapeutics is pioneering REVO-U, a next-generation gene-editing–free universal CAR-T platform that delivers industrial-scale manufacturing, deep clinical responses, and zero GvHD risk — making cell therapy accessible to every patient who needs it.
RevoCAR
RevoCAR
CAR-T cells are genetically engineered T cells that express chimeric antigen receptors (CARs). The CAR is a fusion protein consisting of three key components: an antibody-derived extracellular antigen-binding domain, a transmembrane domain, and intracellular signaling domains from the T cell receptor complex.
Committed to pioneering the next generation of CAR-T therapies, we sincerely invite you to join us!
  • North Area, Building E, Floors 3-4, Qianhai Shenzhen-Hong Kong Youth Innovation Hub, Nanshan District, Shenzhen, Guangdong Province, China
  • 0755-86971801

微信公众号

Copyright © 2024 Wondercel Therapeutics Powered by vancheer